HUBOT, INC. — SEC Form D Filing
HUBOT, INC. filed an SEC Form D on April 7, 2026, reporting $5.50M raised in Pharmaceuticals.
Form D filing details
- Filing
- SEC Form D
- Filing date
- April 7, 2026
- Amount reported
- $5.50M
- Round stage
- Seed
- Industry
- Pharmaceuticals
- Website
- https://hubot.github.com/
What the company does
Securities: Equity. Revenue: $25,000,001 - $100,000,000. Exemption: Rule 506(b). Incorporated: INDIANA
Problem
Pharmaceutical companies often struggle with drug discovery and development processes.
Solution
HUBOT provides technology solutions that streamline drug discovery and enhance collaboration in the pharmaceutical industry.
Verdict
Investors said yes at this moment because they perceived HUBOT's technology as a potential game changer in the challenging drug discovery landscape, not because the narrative provided a clear picture of who specifically would pay for it. They were implicitly betting on a broader need for innovation in pharmaceuticals amid increasing competition, but the lack of specification regarding buyers and budget owners limited the narrative's upside and durability.
Source: SEC EDGAR Form D filing